Document Detail


Phorbol ester-induced monocytic differentiation is associated with G2 delay and down-regulation of cdc25 expression.
MedLine Citation:
PMID:  8466854     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Treatment of human U-937 myeloid leukemia cells with 12-O-tetradecanoylphorbol-13-acetate (TPA) is associated with growth arrest and induction of monocytic differentiation. The present results demonstrate that exposure of G1- or S phase-enriched U-937 cells to TPA was associated with delayed transition through G2-M and then exit from the cell cycle in the subsequent G0-G1 phase. In contrast, G2-M cells treated with TPA progressed through G1-S, were delayed in the next G2-M phase, and then entered a nonproliferative G0-G1 state. The effects of TPA on expression of cell cycle control genes demonstrated down-regulation of the cdc25 mitotic inducer during S-G2 progression. In order to investigate the role of cdc25 in the control of cell cycle progression, U-937 cells were stably transfected with an antisense cdc25 construct under control of a metallothionein-inducible promoter. Expression of this construct in G1 phase cells was associated with a significant delay in transition through S and G2-M phase. Similar results were obtained when G1 phase cells were incubated with a 14-base pair antisense cdc25 oligomer. Taken together, these results indicate that the cdc25 gene product is functionally associated with S-G2 transition of proliferating myeloid leukemia cells and that down-regulation of this gene by TPA is associated with G2-M delay.
Authors:
R Hass; H Gunji; M Hirano; R Weichselbaum; D Kufe
Related Documents :
2542004 - Second messenger signaling in the regulation of collagenase production by osteogenic sa...
21597754 - Cultured chinese-hamster ovary cells lack a transferable x-radiation resistance factor.
12118064 - Suppression of synaptotagmin ii restrains phorbolester-induced downregulation of protei...
9645454 - Expression of the active form of mmp-2 on the surface of leukemic cells accounts for th...
22441874 - Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell...
11731454 - Notch-delta signaling induces a transition from mitotic cell cycle to endocycle in dros...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research     Volume:  4     ISSN:  1044-9523     ISO Abbreviation:  Cell Growth Differ.     Publication Date:  1993 Mar 
Date Detail:
Created Date:  1993-05-11     Completed Date:  1993-05-11     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9100024     Medline TA:  Cell Growth Differ     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  159-66     Citation Subset:  IM    
Affiliation:
Laboratory of Clinical Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Base Sequence
Cell Differentiation / drug effects
Down-Regulation / drug effects
G2 Phase / drug effects*
Gene Expression / drug effects*
Humans
Leukemia, Myeloid / drug therapy*,  genetics
Molecular Sequence Data
Monocytes / cytology,  drug effects*
S Phase / drug effects*
Tetradecanoylphorbol Acetate / pharmacology*
Time Factors
Grant Support
ID/Acronym/Agency:
CA42802/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
16561-29-8/Tetradecanoylphorbol Acetate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation.
Next Document:  Predominant expression of nPKC eta, a Ca(2+)-independent isoform of protein kinase C in epithelial t...